HomeHealth

Health

Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer

Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer

August 19, 2020

BioMarin Receives Complete Response Letter (CRL) from FDA for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A

BioMarin Receives Complete Response Letter (CRL) from FDA for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A

August 19, 2020

Alkermes Initiates Phase 2 Study Designed to Evaluate Clinical and Immunologic Activity of ALKS 4230 on Tumor Microenvironment in Patients with Advanced Solid Tumors

Alkermes Initiates Phase 2 Study Designed to Evaluate Clinical and Immunologic Activity of ALKS 4230 on Tumor Microenvironment in Patients with Advanced Solid Tumors

August 19, 2020

Innovative Medical Devices Help Healthcare Systems Become More Efficient

Innovative Medical Devices Help Healthcare Systems Become More Efficient

August 19, 2020

PTC Therapeutics’ Application for SMA Drug Accepted by EU

PTC Therapeutics’ Application for SMA Drug Accepted by EU

August 18, 2020

Bristol Myers & Dragonfly Team Up for Immunotherapy Program

Bristol Myers & Dragonfly Team Up for Immunotherapy Program

August 18, 2020

Gilead Expands Collaboration With Tango for Cancer Therapies

Gilead Expands Collaboration With Tango for Cancer Therapies

August 18, 2020

Novavax Begins Phase IIb Coronavirus Vaccine Study in South Africa

Novavax Begins Phase IIb Coronavirus Vaccine Study in South Africa

August 18, 2020

FDA Nods to Emergent’s (EBS) Narcan Shelf Life Extension

FDA Nods to Emergent’s (EBS) Narcan Shelf Life Extension

August 18, 2020

Unity Shares Slump 66% As Lead Arthritis Drug Fails in Study

Unity Shares Slump 66% As Lead Arthritis Drug Fails in Study

August 18, 2020

« 1 … 873 874 875 876 877 … 942 »